A PET Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants
CN0140003
Phase 1 other active
Quick answer
A PET Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants for Neuropsychiatric indications and potentially other conditions is a Phase 1 program (other) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Neuropsychiatric indications and potentially other conditions
- Phase
- Phase 1
- Modality
- other
- Status
- active